首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 基因疗法

市场调查报告书

商品编码

1590308

CGT（细胞和基因疗法）工具和试剂：全球市场

Cell and Gene Therapy Tools, and Reagents: Global Markets

出版日期: 2024年11月07日 | 出版商:

BCC Research | 英文 136 Pages | 订单完成后即时交付

价格

简介目录图表

全球 CGT（细胞和基因治疗）工具和试剂市场规模预计将从 2024 年的 100 亿美元增至 2029 年的 167 亿美元，预测期内复合年增长率为 10.8%。

北美市场预计将从2024年的46亿美元成长到2029年的82亿美元，复合年增长率为12.1%。欧洲市场预计将从2024年的26亿美元成长到2029年的43亿美元，复合年增长率为10.5%。

该报告调查了全球 CGT（细胞和基因治疗）工具和试剂市场，提供了市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势以及市场规模趋势，详细 - 编译预测。品类、地区分析、竞争状况、主要企业概况等

市场动态
市场驱动因素
资本利得税研究投资
扩大临床和商业生产能力
慢性病发生率增加
合作与收购
市场限制因素
製造和供应链的复杂性
缺乏熟练人才
市场机会
利用 CGT 技术的进步
监管状况
基因治疗法规
细胞治疗法规
病毒载体和非病毒载体
中等的
GMP 蛋白和抗体
白血球去除手术
欧洲资本利得税法规

第四章新兴科技与发展

封闭式自动化系统
免洗技术

第五章市场区隔分析

市场趋势
细分细分
全球 CGT 工具和试剂市场：按产品
免疫检测
反应器
白血球去除手术
GMP抗体
多重免疫检测
向量
细胞分离
冷冻保存
细胞增殖
中等的
GMP蛋白
GMP小分子
CRS监控
全球 CGT 工具和试剂市场：按应用分类
癌症
罕见疾病
其他疾病
全球 CGT 工具和试剂市场：按最终用户分类
製药和生物技术公司
学术研究所
临床实验室
地域分布
全球 CGT 工具和试剂市场：按地区
北美洲
欧洲
亚太地区
其他领域

第六章竞争讯息

主要企业排名
主要企业策略
产品发布
协作伙伴伙伴关係
扩张
协定
获得
其他的

第七章 CGT 工具和试剂市场的永续性：ESG 视角

ESG：简介
产业ESG表现
CGT 工具和试剂产业的 ESG 实践
环境绩效
BCC的结语

第8章附录

调查方法
简称
参考
公司简介
ABCAM LTD.
ADVERUM BIOTECHNOLOGIES INC.
AKRON BIOTECH
BIO-RAD LABORATORIES INC.
BIO-TECHNE
CYTIVA
FUJIFILM IRVINE SCIENTIFIC
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
QIAGEN
REVVITY
SARTORIUS CELLGENIX GMBH
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.

简介目录图表

Product Code: BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

The North American market for CGT Tools and Reagents is estimated to increase from $4.6 billion in 2024 to reach $8.2 billion by 2029, at a CAGR of 12.1% from 2024 through 2029.

The European market for CGT Tools and Reagents is estimated to increase from $2.6 billion in 2024 to reach $4.3 billion by 2029, at a CAGR of 10.5% from 2024 through 2029.

Report Scope

This report analyzes the global market for cell and gene therapy tools and reagents. The market is segmented by product type, disease or application, end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. Diseases or applications include cancer and rare diseases. End users include pharmaceutical and biotech companies, academic research institutes, and clinical laboratories. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape, and analyzes macroeconomic factors when considering new technologies, the industry's increasing competitiveness, and emerging customer needs. This report also examines analytical frameworks, such as ESG analysis, patent analysis, competitive analysis, and strategic recommendations, which will aid companies in devising their strategic plans.

Report Includes

44 data tables and 57 additional tables
An update on the global market for cell and gene therapy tools and reagents
Analyses of the global market trends, with historic market revenue for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
A look at the market potential for the cell and gene therapy tools and reagents in the life sciences industry, market drivers, and forecasts for the market segments of product, application, end user and region
Facts and figures pertaining to major market dynamics, product innovations, clinical trials, and government regulations
Review of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
Coverage of the technological, economic and business considerations of the market, and the vendor landscape
Analysis of the industry's regulatory framework and policies, and product pipeline
Discussion of ESG challenges and ESG practices in the industry
Market share analysis of the key companies in the industry and coverage of their proprietary technologies and strategies
Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Sartorius CellGenix GmbH, and Miltenyi Biotec

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Technology Background: Cell Therapy
Types of Cell Therapy
Technology Background: Gene Therapy
Types of Gene Therapy
Approved CGT Products

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Investments in CGT Research
Capacity Expansions for Clinical and Commercial Manufacturing
Increasing Incidence of Chronic Diseases
Collaborations and Acquisitions
Market Restraints
Complexity in Manufacturing and Supply Chain
Lack of Skilled Force
Market Opportunities
Harnessing the Advances in CGT Technologies
Regulatory Landscape
Gene Therapy Regulations
Cell Therapy Regulations
Viral and Non-Viral Vectors
Media
GMP Proteins and Antibodies
Leukapheresis
CGT Regulations in Europe

Chapter 4 Emerging Technologies and Developments

Closed and Automated Systems
Single-Use Technologies

Chapter 5 Market Segmentation Analysis

Market Trends
Segmentation Breakdown
Global Market for CGT Tools and Reagents, by Product
Immunoassays
Bioreactors
Leukapheresis
GMP Antibodies
Multiplex Immunoassays
Vectors
Cell Separation
Cryopreservation
Cell Expansion
Media
GMP Proteins
GMP Small Molecules
CRS Monitoring
Global Market for CGT Tools and Reagents, by Application
Cancer
Rare Diseases
Other Diseases
Global Market for CGT Tools and Reagents, by End User
Pharmaceutical and Biotech Companies
Academic and Research Institutes
Clinical Laboratories
Geographic Breakdown
Global Market for CGT Tools and Reagents, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Ranking of Leading Players
Strategies of Leading Companies
Product Launches
Collaborations and Partnerships
Expansions
Agreements
Acquisitions
Others

Chapter 7 Sustainability in the CGT Tool and Reagent Market: ESG Perspective

Introduction to ESG
ESG Performance in the Industry
ESG Practices in the CGT Tool and Reagent Industry
Environmental Performance
Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology
Abbreviations
References
Company Profiles
ABCAM LTD.
ADVERUM BIOTECHNOLOGIES INC.
AKRON BIOTECH
BIO-RAD LABORATORIES INC.
BIO-TECHNE
CYTIVA
FUJIFILM IRVINE SCIENTIFIC
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
QIAGEN
REVVITY
SARTORIUS CELLGENIX GMBH
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.

简介目录图表

List of Tables

Summary Table A : Global Market for CGT Tools and Reagents, by Application, Through 2029
Summary Table B : Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 1 : Approved CGT Products, as of 2024
Table 2 : Global Cancer Statistics, 2022
Table 3 : Global Market for CGT Tools and Reagents, by Product, Through 2029
Table 4 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
Table 5 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
Table 6 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
Table 7 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
Table 8 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
Table 9 : Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
Table 10 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
Table 11 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
Table 12 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
Table 13 : Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
Table 14 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
Table 15 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
Table 16 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
Table 17 : Global Market for CGT Tools and Reagents, by Application, Through 2029
Table 18 : Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
Table 19 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
Table 20 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
Table 21 : Global Market for CGT Tools and Reagents, by End User, Through 2029
Table 22 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
Table 23 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
Table 24 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
Table 25 : Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 26 : North American Market for CGT Tools and Reagents, by Product, Through 2029
Table 27 : North American Market for CGT Tools and Reagents, by Application, Through 2029
Table 28 : North American Market for CGT Tools and Reagents, by End User, Through 2029
Table 29 : European Research Initiatives Focused on Personalized Medicine
Table 30 : European Market for CGT Tools and Reagents, by Product, Through 2029
Table 31 : European Market for CGT Tools and Reagents, by Application, Through 2029
Table 32 : European Market for CGT Tools and Reagents, by End User, Through 2029
Table 33 : Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
Table 34 : Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
Table 35 : Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
Table 36 : RoW Market for CGT Tools and Reagents, by Product, Through 2029
Table 37 : RoW Market for CGT Tools and Reagents, by Application, Through 2029
Table 38 : RoW Market for CGT Tools and Reagents, by End User, Through 2029
Table 39 : Leading Companies in the CGT Tool and Reagent Market, 2023
Table 40 : Product Launches in the Market for CGT Tools and Reagents, 2021-2024
Table 41 : Collaborations and Partnerships in the CGT Tool and Reagent Market, 2022-2024
Table 42 : Expansions in the Market for CGT Tools and Reagents, 2022-2024
Table 43 : Agreements in the Market for CGT Tools and Reagents, 2022-2024
Table 44 : Acquisitions in the CGT Market for Tools and Reagents, 2022-2024
Table 45 : Other Developments in the Market for CGT Tools and Reagents, 2023 and 2024
Table 46 : Focus Areas in ESG Metrics
Table 47 : Environmental Performance Initiatives in the CGT Tool and Reagent Market
Table 48 : Social Performance Initiatives in the CGT Tool and Reagent Market
Table 49 : Governance Performance Initiatives in the CGT Tool and Reagent Market
Table 50 : ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
Table 51 : Abbreviations Used in this Report
Table 52 : Abcam Ltd.: Company Snapshot
Table 53 : Abcam Ltd.: Financial Performance, FY 2022 and 2023
Table 54 : Abcam Ltd.: Product Portfolio
Table 55 : Abcam Ltd.: News/Key Developments, 2022 and 2023
Table 56 : Adverum Biotechnologies Inc.: Company Snapshot
Table 57 : Adverum Biotechnologies Inc.: Financial Performance, FY 2022 and 2023
Table 58 : Adverum Biotechnologies Inc.: Product Portfolio
Table 59 : Adverum Biotechnologies Inc.: News/Key Developments, 2022-2024
Table 60 : Akron Biotech: Company Snapshot
Table 61 : Akron Biotech: Product Portfolio
Table 62 : Akron Biotech: News/Key Developments, 2022-2024
Table 63 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 64 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 65 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 66 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 67 : Bio-Techne: Company Snapshot
Table 68 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 69 : Bio-Techne: Product Portfolio
Table 70 : Bio-Techne: News/Key Developments, 2023 and 2024
Table 71 : Cytiva: Company Snapshot
Table 72 : Cytiva: Product Portfolio
Table 73 : Cytiva: News/Key Developments, 2023 and 2024
Table 74 : FUJIFILM Irvine Scientific: Company Snapshot
Table 75 : FUJIFILM Irvine Scientific: Product Portfolio
Table 76 : FUJIFILM Irvine Scientific: News/Key Developments, 2022 and 2023
Table 77 : Miltenyi Biotec: Company Snapshot
Table 78 : Miltenyi Biotec: Product Portfolio
Table 79 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 80 : Proteintech Group Inc.: Company Snapshot
Table 81 : Proteintech Group Inc.: Product Portfolio
Table 82 : QIAGEN: Company Snapshot
Table 83 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 84 : QIAGEN: Product Portfolio
Table 85 : QIAGEN: News/Key Developments, 2022-2024
Table 86 : Revvity: Company Snapshot
Table 87 : Revvity: Financial Performance, FY 2022 and 2023
Table 88 : Revvity: Product/Solutions Portfolio
Table 89 : Revvity: News/Key Developments, 2023 and 2024
Table 90 : Sartorius CellGenix GmbH: Company Snapshot
Table 91 : Sartorius CellGenix GmbH: Product Portfolio
Table 92 : Sartorius CellGenix GmbH: News/Key Developments, 2023 and 2024
Table 93 : STEMCELL Technologies: Company Snapshot
Table 94 : STEMCELL Technologies: Product Portfolio
Table 95 : STEMCELL Technologies: News/Key Developments, 2022-2024
Table 96 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 97 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 98 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 99 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023

List of Figures

Summary Figure A : Global Market for CGT Tools and Reagents, by Application, 2021-2029
Summary Figure B : Global Market for CGT Tools and Reagents, by Region, 2021-2029
Figure 1 : Market Dynamics of CGT Tools and Reagents
Figure 2 : CGT Sector Investments, 2018-2023
Figure 3 : CGT Sector Investments, by Deal Type, Q1 2024
Figure 4 : Global Market Shares of CGT Tools and Reagents, by Product, 2024
Figure 5 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
Figure 6 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
Figure 7 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
Figure 8 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
Figure 9 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
Figure 10 : Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
Figure 11 : Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
Figure 12 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
Figure 13 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
Figure 14 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
Figure 15 : Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
Figure 16 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
Figure 17 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
Figure 18 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
Figure 19 : Global Market Shares of CGT Tools and Reagents, by Application, 2024
Figure 20 : Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
Figure 21 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
Figure 22 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
Figure 23 : Global Market Shares of CGT Tools and Reagents, by End User, 2024
Figure 24 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
Figure 25 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
Figure 26 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
Figure 27 : Global Market Shares of CGT Tools and Reagents, by Region, 2024
Figure 28 : North American Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 29 : North American Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 30 : North American Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 31 : European Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 32 : European Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 33 : European Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 34 : Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 35 : Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 36 : Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 37 : RoW Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 38 : RoW Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 39 : RoW Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 40 : How a Strong ESG Proposition Benefits Businesses
Figure 41 : Abcam Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : Abcam Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 44 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 46 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 47 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 48 : QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 49 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 50 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 51 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023